Efficacy and Safety of Ribupatide Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes
Recruiting now · Phase 3 · Has a placebo group
Conditions studied: Obesity
In brief
The primary objective of this study is to demonstrate that ribupatide (KAI-9531) subcutaneous (SC) injection once weekly is superior to semaglutide SC once weekly and to placebo SC once weekly on percent change in body weight.
Key facts
- Study ID
- NCT07284979
- Run by
- Kailera
- People needed
- 1200
- Starts
- 2025-12-30
- Expected to finish
- 2028-04-01
- Last updated by the study team
- 2026-07-22
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Kailera Clinical Site — Phoenix, Arizona, United States (enrolling)
- Kailera Clinical Site — Little Rock, Arkansas, United States (enrolling)
- Kailera Clinical Site — Northridge, California, United States (enrolling)
- Kailera Clinical Site — Oceanside, California, United States (enrolling)
- Kailera Clinical Site — Hamden, Connecticut, United States (enrolling)
- Kailera Clinical Site — Stamford, Connecticut, United States (enrolling)
- Kailera Clinical Site — Orange City, Florida, United States (enrolling)
- Kailera Clinical Site — Albany, Georgia, United States (enrolling)
- Kailera Clinical Site — Chicago, Illinois, United States (enrolling)
- Kailera Clinical Site — Skokie, Illinois, United States (enrolling)
- Kailera Clinical Site — Newton, Kansas, United States (enrolling)
- Kailera Clinical Site — Shreveport, Louisiana, United States (enrolling)
- Kailera Clinical Site — Farmington Hills, Michigan, United States (enrolling)
- Kailera Clinical Site — Missoula, Montana, United States (enrolling)
- Kailera Clinical Site — Las Vegas, Nevada, United States (enrolling)
- Kailera Clinical Site — Albany, New York, United States (enrolling)
- Kailera Clinical Site — Morehead City, North Carolina, United States (enrolling)
- Kailera Clinical Site — Morrisville, North Carolina, United States (enrolling)
- Kailera Clinical Site — Norman, Oklahoma, United States (enrolling)
- Kailera Clinical Site — East Greenwich, Rhode Island, United States (enrolling)
- Kailera Clinical Site — North Charleston, South Carolina, United States (enrolling)
- Kailera Clinical Site — Spartanburg, South Carolina, United States (enrolling)
- Kailera Clinical Site — Brownsville, Texas, United States (enrolling)
- Kailera Clinical Site — San Antonio, Texas, United States (enrolling)
- Kailera Clinical Site — Glendale, Arizona, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.